Physician profile
Joseph Pongetti
NPI 1912647595
$5,298.73
in general payments reported to CMS, 2019-2025
13 companies · $4,826 in 2025
The $4,826 reported for 2025 was more than what 98% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $185 · 2024: $288 · 2025: $4,826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,025 · Travel and Lodging: $2,274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,024.87 |
| Travel and Lodging | $2,273.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $2,116.00 | 2025 | |
| Boston Scientific Corporation | $1,235.68 | 2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Biotronik Nro, INC. | $484.22 | 2025 | Prospera |
| Inari Medical, INC. | $473.22 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stratus Medical, LLC | $190.27 | 2025 | Nimbus |
| Stryker Corporation | $175.00 | 2025 | Artix Mt, Clottriever Bold Catheter, Flowtriever |
| Abbott Laboratories | $140.30 | 2025 | Eterna |
| Avanos Medical | $133.85 | 2025 | Coolief Cooled Radiofrequency |
| Nalu Medical, INC. | $128.23 | 2025 | Nalu Neurostimulation System |
| Fisher & Paykel Healthcare INC | $101.74 | 2025 | Fisher & Paykel Healthcare |
| Medtronic, INC. | $50.35 | 2025 | Vanta Adaptivestim |
| Averitas Pharma INC. | $43.62 | 2025 | Qutenza |
| Lundbeck LLC | $26.25 | 2025 | Vyepti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Pongetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.